Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1999
12/23/1999WO1999066059A1 Novel fragmentation vectors and uses thereof
12/23/1999WO1999066058A2 Materials and methods for amplifying and enhanced transcribing of polynucleotides in plants and portions thereof
12/23/1999WO1999066057A2 Inducible promoters
12/23/1999WO1999066056A1 Method for obtaining modified polysaccharides
12/23/1999WO1999066055A2 Plant pathogen inducible control sequences operably linked to cell cycle genes and the uses thereof
12/23/1999WO1999066054A2 Erythropoietin analog-human serum albumin fusion protein
12/23/1999WO1999066053A1 Expression vector for use in a one-step purification protocol
12/23/1999WO1999066052A1 GENES CODING FOR β-AGARASES AND THEIR USE FOR PRODUCING AGAR BIODEGRADATION ENZYMES
12/23/1999WO1999066051A2 Nek-related and bub1-related protein kinases
12/23/1999WO1999066050A1 Improvements in or relating to plants and plant products
12/23/1999WO1999066049A2 A novel gene and method of treating a gram negative bacterial infection
12/23/1999WO1999066048A1 A mutant human hepatitis b viral strain and uses thereof
12/23/1999WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999WO1999066046A1 Hiv virus mimotopes
12/23/1999WO1999066045A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays
12/23/1999WO1999066044A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs
12/23/1999WO1999066043A1 Recombinant production of toxoplasma sag1 antigen
12/23/1999WO1999066042A1 Dna sequences which code a glucose-translocator, plasmids, bacteria, yeasts and plants containing this translocator
12/23/1999WO1999066041A1 94 human secreted proteins
12/23/1999WO1999066040A1 Immunomodulator polypeptide, zsig57
12/23/1999WO1999066039A1 Tnfr-like protein with death domain
12/23/1999WO1999066038A1 Angiostatin-binding protein
12/23/1999WO1999066037A2 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/23/1999WO1999066036A1 Transplants for myocardial scars
12/23/1999WO1999066035A2 Vector construction by host cell-mediated recombination
12/23/1999WO1999066034A1 Process for conversion of germplasm
12/23/1999WO1999066032A2 Cells, genetically modified with optical marker
12/23/1999WO1999066029A2 Gibberelin 2-oxidase
12/23/1999WO1999066028A2 Genes for the biosynthesis of epothilones
12/23/1999WO1999066026A2 Methods and means for expression of mammalian polypeptides in monocotyledonous plants
12/23/1999WO1999066024A1 Methods of monitoring disease states and therapies using gene expression profiles
12/23/1999WO1999065992A1 An anthraquinone and its derivatives
12/23/1999WO1999065947A2 Monoclonal antibodies directed against the g3bp protein, and uses
12/23/1999WO1999065943A1 A method for the removal/purification of serum albumins and means for use in the method
12/23/1999WO1999065940A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12
12/23/1999WO1999065938A2 Fy7 polymerase
12/23/1999WO1999065937A2 Truncated apaf-1 and methods of use thereof
12/23/1999WO1999065927A2 Method for producing polynucleotides with desired properties
12/23/1999WO1999065926A1 Method for marking a ribonucleic acid and resulting marked rna fragments
12/23/1999WO1999065925A1 Targeted oligonucleotide conjugates
12/23/1999WO1999065924A2 Preparation and use of superior vaccines
12/23/1999WO1999065712A2 Glycosulfopeptides and methods of synthesis and use thereof
12/23/1999WO1999065531A1 Polymers for delivery of nucleic acids
12/23/1999WO1999065530A1 NrdD
12/23/1999WO1999065521A1 Methods and materials for the treatment of prostatic carcinoma
12/23/1999WO1999065515A2 Combination of radiotherapy and anti-angiogenic factors
12/23/1999WO1999065511A2 Composition and method for treatment of pseudomonas infection
12/23/1999WO1999065502A1 Oligonucleotides for enhanced modulation of protein kinase c expression
12/23/1999WO1999065461A2 Cationic amphiphile micellar complexes
12/23/1999WO1999065292A1 Methods for generating and identifying mutant polyploid plants, and uses therefor
12/23/1999WO1999055832A3 Nucleic acid encoding rate agouti related protein
12/23/1999WO1999055829A3 Process for preparing doxorubicin
12/23/1999WO1999054493A3 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
12/23/1999WO1999053960A3 Enhancing immune responses to genetic immunization by using a chemokine
12/23/1999WO1999053319A3 High-density, miniaturized arrays and methods of manufacturing same
12/23/1999WO1999053043A3 Herpes simplex virus latency associated transcript polypeptides
12/23/1999WO1999053018A3 Purification of cellular components that are substantially rna free
12/23/1999WO1999051741A3 Lyst protein complexes and lyst interacting proteins
12/23/1999WO1999051629A3 New compounds for dna-transfection
12/23/1999WO1999050428A3 Pathogen-inducible promoter
12/23/1999WO1999047649A3 Polymerase chimeras
12/23/1999WO1999047558A3 T cell costimulatory proteins, sequences and uses thereof
12/23/1999WO1999045098A3 Delivery or proteins into eukaryotic cells with recombinant yersinia
12/23/1999WO1999043830A9 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity
12/23/1999WO1999042589A3 Insecticidal toxins from photorhabdus
12/23/1999WO1999042578A3 Modulation of cell proliferation, methods and reagents
12/23/1999WO1999041364A3 Compositions and methods for wound healing
12/23/1999WO1999040212A3 Bacteriophage vectors generated by bacteriophage/plasmid recombination
12/23/1999WO1999038972A3 Human genes and gene expression products ii
12/23/1999WO1999033982A3 Human genes and gene expression products i
12/23/1999WO1999033871A3 Essential bacterial genes and their use
12/23/1999WO1999033869A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
12/23/1999WO1999029904A3 Methods and reagents for preservation of dna in bodily fluids
12/23/1999WO1999028748A3 Hla-e binding
12/23/1999WO1998032326A3 Methods for $i(agrobacterium)-mediated transformation
12/23/1999DE19928591A1 Production of polymers from nucleotide and/or non-nucleotide units using RNA ligase, useful for
12/23/1999DE19829660C1 Transgenic non-human mammal useful for testing compounds for anticancer activity
12/23/1999DE19822122A1 Humane deadenylierende Nuclease, ihre Herstellung und Verwendung Human deadenylierende nuclease, their preparation and use
12/23/1999DE19812375C1 Für Tumorsuppressorproteine codierende Nucleinsäure, Tumorsuppressorproteine, Verfahren zu deren Herstellung, Antikörper gegen Tumorsuppressorproteine und Verwendung dieser Gegenstände For nucleic acid coding for tumor suppressor proteins, tumor suppressor proteins, processes for their preparation, to antibodies against tumor suppressor proteins and use of these articles
12/23/1999CA2541920A1 A bioluminescence resonance energy transfer (bret) system and its use
12/23/1999CA2335638A1 Cationic amphiphile micellar complexes
12/23/1999CA2335460A1 Polymers for delivery of nucleic acids
12/23/1999CA2335452A1 Preparation and use of superior vaccines
12/23/1999CA2335337A1 Methods and materials for the treatment of prostatic carcinoma
12/23/1999CA2335299A1 Methods of monitoring disease states and therapies using gene expression profiles
12/23/1999CA2335269A1 Method for producing polynucleotides with desired properties
12/23/1999CA2335248A1 Transplants for myocardial scars
12/23/1999CA2335187A1 Methods for testing biological network models
12/23/1999CA2335038A1 Combination of radiotherapy and anti-angiogenic factors
12/23/1999CA2334165A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays
12/23/1999CA2333602A1 Expression vector for use in a one-step purification protocol
12/23/1999CA2332563A1 Glycosulfopeptides and methods of synthesis and use thereof
12/23/1999CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999CA2331889A1 Nek-related and bub1-related protein kinases
12/23/1999CA2331880A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs
12/23/1999CA2331788A1 Polymerase signaling assay
12/23/1999CA2331767A1 Denaturing gradient affinity electrophoresis and methods of use thereof
12/23/1999CA2331384A1 Nucleic acid transfer phage
12/23/1999CA2331382A1 Interaction of p27(kip1) with fkbp-12
1 ... 3308 3309 3310 3311 3312 3313 3314 3315 3316 3317 3318 3319 3320 3321 3322 3323 3324 3325 3326 3327 3328 ... 4023